These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 22467195)

  • 1. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings.
    Hou H; Wang C; Jia S; Hu S; Tian M
    Neurosci Bull; 2014 Oct; 30(5):765-76. PubMed ID: 25260796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of addiction: insight from neurochemical imaging.
    Urban NB; Martinez D
    Psychiatr Clin North Am; 2012 Jun; 35(2):521-41. PubMed ID: 22640769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Dopamine Signaling in Drug Addiction.
    Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
    Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction.
    Martinez D; Saccone PA; Liu F; Slifstein M; Orlowska D; Grassetti A; Cook S; Broft A; Van Heertum R; Comer SD
    Biol Psychiatry; 2012 Feb; 71(3):192-8. PubMed ID: 22015315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO.
    Boileau I; Nakajima S; Payer D
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1410-20. PubMed ID: 26141509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging neurotransmitter release by drugs of abuse.
    Martinez D; Narendran R
    Curr Top Behav Neurosci; 2010; 3():219-45. PubMed ID: 21161755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation.
    Gould RW; Porrino LJ; Nader MA
    Curr Top Behav Neurosci; 2012; 11():25-44. PubMed ID: 22020537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rewarding, reinforcing and incentive salient events involve orexigenic hypothalamic neuropeptides regulating mesolimbic dopaminergic neurotransmission.
    Quarta D; Smolders I
    Eur J Pharm Sci; 2014 Jun; 57():2-10. PubMed ID: 24472703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies.
    Volkow ND; Fowler JS; Wang GJ
    Behav Pharmacol; 2002 Sep; 13(5-6):355-66. PubMed ID: 12394411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.
    Laruelle M
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):423-51. PubMed ID: 10724107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food addiction: A common neurobiological mechanism with drug abuse.
    Lindgren E; Gray K; Miller G; Tyler R; Wiers CE; Volkow ND; Wang GJ
    Front Biosci (Landmark Ed); 2018 Jan; 23(5):811-836. PubMed ID: 28930574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET evaluation of the dopamine system of the human brain.
    Volkow ND; Fowler JS; Gatley SJ; Logan J; Wang GJ; Ding YS; Dewey S
    J Nucl Med; 1996 Jul; 37(7):1242-56. PubMed ID: 8965206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine addiction: hypothesis derived from imaging studies with PET.
    Volkow ND; Ding YS; Fowler JS; Wang GJ
    J Addict Dis; 1996; 15(4):55-71. PubMed ID: 8943582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatocortical pathway dysfunction in addiction and obesity: differences and similarities.
    Tomasi D; Volkow ND
    Crit Rev Biochem Mol Biol; 2013; 48(1):1-19. PubMed ID: 23173916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor mapping with PET imaging in Parkinson's disease.
    Niccolini F; Su P; Politis M
    J Neurol; 2014 Dec; 261(12):2251-63. PubMed ID: 24627109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET imaging for addiction medicine: From neural mechanisms to clinical considerations.
    Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ
    Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation.
    Nader MA; Czoty PW
    Am J Psychiatry; 2005 Aug; 162(8):1473-82. PubMed ID: 16055768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic function and intertemporal choice.
    Joutsa J; Voon V; Johansson J; Niemelä S; Bergman J; Kaasinen V
    Transl Psychiatry; 2015 Jan; 5(1):e491. PubMed ID: 25562841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating positron emission tomography studies in animals to stimulant addiction: promises and pitfalls.
    Caprioli D; Fryer TD; Sawiak SJ; Aigbirhio FI; Dalley JW
    Curr Opin Neurobiol; 2013 Aug; 23(4):597-606. PubMed ID: 23664005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.